NCODA 2022 Fall Summit Recap

Two of our BOPA members, Sadia Malik (Digital and E & T Subcommittee member) and Rebecca Devine (Executive committee member) attended the NCODA (National Community Oncology Dispensing Association) Fall Summit kindly funded through BOPA and NCODA’s new collaboration. This international partnership will help both organisations to support one another with sharing guidance, experience and practice to support the horizon scanning of both organisations. Sadia and Rebecca will be presenting their experience and thoughts of the NCODA Fall Summit at the BOPA Symposium 2023.

This newsletter is a summary from NCODA of the presentations and discussions that took place at this summit. We look forward to hearing a more detailed presentation at the BOPA Symposium 2023.

Click here to access the newsletter: https://www.bopa.org.uk/resources/ncoda-2022-fall-summit-recap/

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article